Circulating tumor cell number predicts time to progression (TTP) in patients with heavily pretreated gynecological cancers treated with selinexor (SEL)

Authors :: Anne L Kranich
Mansoor Raza Mirza
Jean-Richard Saint-Martin
Patrick Berteloot
J. Meade
Bente Lund
Z Ujmajuridze
Eran Shacham
H. Havsteen
Ignace Vergote
Els Van Nieuwenhuysen
Tami Rashal
Marsha Crochiere
S. Shacham
Yosef Landesman
George Wright
Morten Mau-Sørensen
Trine Juhler-Nøttrup
Charlotte Aaquist Haslund
M. Kauffman
Source :: Crochiere, M, Vergote, I B, Lund, B, Havsteen, H, Ujmajuridze, Z, Van Nieuwenhuysen, E, Haslund, C, Juhler-Nottrup, T, Mau-Sorensen, M, Berteloot, P, Kranich, A L, Meade, J, Wright, G, Shacham, E, Rashal, T, Saint-Martin, J-R, Shacham, S, Kauffman, M, Mirza, M R & Landesman, Y 2016, ' Circulating tumor cell number predicts time to progression (TTP) in patients with heavily pretreated gynecological cancers treated with selinexor (SEL) ', Annals of Oncology, vol. 27, no. Suppl. 6, 886P . https://doi.org/10.1093/annonc/mdw374.33
Publication Year :: 2016

Subjects :: Oncology
medicine.medical_specialty
Circulating tumor cell
business.industry
Time to progression
Internal medicine
medicine
In patient
Hematology
business

Language :: English
Database :: OpenAIRE
Journal :: Crochiere, M, Vergote, I B, Lund, B, Havsteen, H, Ujmajuridze, Z, Van Nieuwenhuysen, E, Haslund, C, Juhler-Nottrup, T, Mau-Sorensen, M, Berteloot, P, Kranich, A L, Meade, J, Wright, G, Shacham, E, Rashal, T, Saint-Martin, J-R, Shacham, S, Kauffman, M, Mirza, M R & Landesman, Y 2016, ' Circulating tumor cell number predicts time to progression (TTP) in patients with heavily pretreated gynecological cancers treated with selinexor (SEL) ', Annals of Oncology, vol. 27, no. Suppl. 6, 886P . https://doi.org/10.1093/annonc/mdw374.33
Accession number :: edsair.doi.dedup.....8800cd3468152a0eee78178095621e54
Full Text :: https://doi.org/10.1093/annonc/mdw374.33

Full Text Access

Tools